Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: Cell type is the most useful prognostic factor-Reference-Cited by-同舟云学术

Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: Cell type is the most useful prognostic factor

Published:2012-07 Issue:10 Volume:48 Page:1476-1483
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Bamias A.,Sotiropoulou M.,Zagouri F.,Trachana P.,Sakellariou K.,Kostouros E.,Kakoyianni K.,Rodolakis A.,Vlahos G.,Haidopoulos D.,Thomakos N.,Antsaklis A.,Dimopoulos M.A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Ovarian tumorigenesis. A proposed model based on morphological and molecular genetic analysis;Shih;Am J Pathol,2004

2. Early events in the pathogenesis of epithelial ovarian cancer;Landen;J Clin Oncol,2008

3. Ovarian low-grade and high-grade serous carcinoma. Pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems;Vang;Adv Anat Pathol,2009

4. A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary;Kobel;Am J Surg Pathol,2009

5. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian cancer;Gilks;Human Pathol,2008

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilizing a Pathomics Biomarker to Predict the Effectiveness of Bevacizumab in Ovarian Cancer Treatment;Bioengineering;2024-07-03

2. Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand;Australian and New Zealand Journal of Obstetrics and Gynaecology;2024-02

3. Effect of tumor type on response to adjuvant platinum-based chemotherapy and prognosis in patients with stage II–IV epithelial ovarian carcinoma;Ginekologia Polska;2023-09-01

4. L1-CAM in Mucinous Ovarian Carcinomas and Borderline Tumors;American Journal of Surgical Pathology;2023-02-28

5. Endometrioid Ovarian Tumours;Essentials of Diagnostic Gynecological Pathology;2023